Last reviewed · How we verify
Intravenous levetiracetam
Intravenous levetiracetam is a Small molecule drug developed by Muhammad Aamir Latif. It is currently in Phase 2 development. Also known as: injection Levera, Keppra.
At a glance
| Generic name | Intravenous levetiracetam |
|---|---|
| Also known as | injection Levera, Keppra |
| Sponsor | Muhammad Aamir Latif |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation (PHASE2)
- Levetiracetam Versus Phenobarbitone for the Treatment of Neonatal Seizures in a Tertiary Care Hospital. (NA)
- Study of Antiepileptic Drug in Generalised Convulsive Status Epilepticus (PHASE3)
- Levetiracetam Treatment of Neonatal Seizures: Safety and Efficacy Phase II Study (PHASE2)
- Levetiracetam for Seizure Prevention After Brain Tumor Surgery (PHASE3)
- Antiseizure Medication in Seizure Networks at Early Acute Brain Injury (PHASE4)
- A Dose Escalation Study of Levetiracetam in the Treatment of Neonatal Seizures (PHASE2)
- Comparison of Intravenous Brivaracetam Versus Levetiracetam in the Management of Status Epilepticus (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Intravenous levetiracetam CI brief — competitive landscape report
- Intravenous levetiracetam updates RSS · CI watch RSS
- Muhammad Aamir Latif portfolio CI
Frequently asked questions about Intravenous levetiracetam
What is Intravenous levetiracetam?
Intravenous levetiracetam is a Small molecule drug developed by Muhammad Aamir Latif.
Who makes Intravenous levetiracetam?
Intravenous levetiracetam is developed by Muhammad Aamir Latif (see full Muhammad Aamir Latif pipeline at /company/muhammad-aamir-latif).
Is Intravenous levetiracetam also known as anything else?
Intravenous levetiracetam is also known as injection Levera, Keppra.
What development phase is Intravenous levetiracetam in?
Intravenous levetiracetam is in Phase 2.
Related
- Manufacturer: Muhammad Aamir Latif — full pipeline
- Also known as: injection Levera, Keppra
- Compare: Intravenous levetiracetam vs similar drugs
- Pricing: Intravenous levetiracetam cost, discount & access